Gerd Dannhardt

3.3k total citations · 1 hit paper
138 papers, 2.8k citations indexed

About

Gerd Dannhardt is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Gerd Dannhardt has authored 138 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Organic Chemistry, 51 papers in Molecular Biology and 32 papers in Pharmacology. Recurrent topics in Gerd Dannhardt's work include Inflammatory mediators and NSAID effects (26 papers), Chemical Synthesis and Analysis (17 papers) and Synthesis and Reactions of Organic Compounds (15 papers). Gerd Dannhardt is often cited by papers focused on Inflammatory mediators and NSAID effects (26 papers), Chemical Synthesis and Analysis (17 papers) and Synthesis and Reactions of Organic Compounds (15 papers). Gerd Dannhardt collaborates with scholars based in Germany, Sweden and Austria. Gerd Dannhardt's co-authors include Werner Kiefer, Stefan Laufer, Holger Ulbrich, Michaela Jansen, Matthias Lehr, Bernd Kohl, Bernd L. Fiebich, J. Augustín, Christian Peifer and Chantragan Srisomsap and has published in prestigious journals such as Blood, Journal of Agricultural and Food Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Gerd Dannhardt

134 papers receiving 2.7k citations

Hit Papers

Cyclooxygenase inhibitors – current status and future pro... 2001 2026 2009 2017 2001 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerd Dannhardt Germany 27 1.6k 742 736 207 158 138 2.8k
John J. Talley United States 25 1.8k 1.1× 1.4k 1.9× 571 0.8× 147 0.7× 299 1.9× 43 3.1k
Francisco Orallo Spain 40 1.7k 1.1× 1.0k 1.4× 1.3k 1.7× 271 1.3× 140 0.9× 106 4.6k
David S. Garvey United States 26 1.2k 0.8× 504 0.7× 935 1.3× 123 0.6× 187 1.2× 54 2.2k
Patrick Dallemagne France 28 1.5k 0.9× 665 0.9× 996 1.4× 214 1.0× 47 0.3× 147 3.0k
Young‐Ger Suh South Korea 31 1.4k 0.9× 535 0.7× 1.6k 2.2× 374 1.8× 178 1.1× 207 4.3k
Jean‐Pierre Hénichart France 30 1.7k 1.0× 545 0.7× 1.8k 2.4× 365 1.8× 91 0.6× 198 3.6k
Pál Perjési Hungary 23 1.1k 0.7× 374 0.5× 860 1.2× 83 0.4× 76 0.5× 132 2.2k
Leonardo Pisani Italy 29 1.5k 0.9× 1.4k 1.9× 810 1.1× 179 0.9× 116 0.7× 74 3.0k
Hiroaki Takayama Japan 33 1.0k 0.7× 766 1.0× 908 1.2× 435 2.1× 104 0.7× 224 4.4k
Marco Macchia Italy 36 1.2k 0.7× 888 1.2× 2.1k 2.8× 361 1.7× 189 1.2× 226 4.3k

Countries citing papers authored by Gerd Dannhardt

Since Specialization
Citations

This map shows the geographic impact of Gerd Dannhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerd Dannhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerd Dannhardt more than expected).

Fields of papers citing papers by Gerd Dannhardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerd Dannhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerd Dannhardt. The network helps show where Gerd Dannhardt may publish in the future.

Co-authorship network of co-authors of Gerd Dannhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Gerd Dannhardt. A scholar is included among the top collaborators of Gerd Dannhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerd Dannhardt. Gerd Dannhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maderer, Annett, et al.. (2014). Moguntinones—New Selective Inhibitors for the Treatment of Human Colorectal Cancer. Molecular Cancer Therapeutics. 13(6). 1399–1409. 6 indexed citations
2.
Lamers, Christina, Friederike Dehm, Isabella Ogorek, et al.. (2014). SAR-studies of γ-secretase modulators with PPARγ-agonistic and 5-lipoxygenase-inhibitory activity for Alzheimer’s disease. Bioorganic & Medicinal Chemistry Letters. 25(4). 841–846. 5 indexed citations
3.
Kiefer, Werner & Gerd Dannhardt. (2005). COX-2 inhibition and pain management: a review summary. Expert Review of Clinical Immunology. 1(3). 431–442. 5 indexed citations
4.
Kiefer, Werner & Gerd Dannhardt. (2004). Novel Insights and Therapeutical Applications in the Field of Inhibitors of COX-2. Current Medicinal Chemistry. 11(24). 3147–3161. 37 indexed citations
5.
Banwell, Martin G., Anna Bezos, Satish Chand, et al.. (2003). Convergent synthesis and preliminary biological evaluations of the stilbenolignan (±)-aiphanol and various congeners. Organic & Biomolecular Chemistry. 1(14). 2427–2429. 20 indexed citations
6.
Ulbrich, Holger & Gerd Dannhardt. (2002). NSAR: Klassifizierung und Wirkspektrum: Eine heterogene Arzneistoffklasse. Pharmazie in unserer Zeit. 31(2). 146–154. 6 indexed citations
7.
Stoyanova, Stefka, et al.. (2002). Inhibitory Activity of Tryptanthrin on Prostaglandin and Leukotriene Synthesis. Planta Medica. 68(10). 875–880. 59 indexed citations
8.
Kohl, Bernd & Gerd Dannhardt. (2001). The NMDA Receptor Complex: A Promising Target for Novel Antiepileptic Strategies. Current Medicinal Chemistry. 8(11). 1275–1289. 73 indexed citations
9.
Dannhardt, Gerd, et al.. (2001). 1-Pyrrolines (3,4-Dihydro-2H-pyrroles) as a Template for New Drugs. Archiv der Pharmazie. 334(6). 183–188. 53 indexed citations
11.
Dannhardt, Gerd & Stefan Laufer. (2000). Structural Approaches to Explain the Selectivity of COX-2 Inhibitors: Is There a Common Pharmacophore?. Current Medicinal Chemistry. 7(11). 1101–1112. 91 indexed citations
12.
Dannhardt, Gerd, et al.. (2000). Benzimidazoles as NMDA Glycine-Site Antagonists: Study on the Structural Requirements in 2-Position of the Ligand. Archiv der Pharmazie. 333(5). 123–129. 11 indexed citations
13.
Dannhardt, Gerd, et al.. (1997). Non‐steroidal Anti‐inflammatory Agents, Part 24[1] Pyrrolidino Enaminones as Models to Mimic Arachidonic Acid. Archiv der Pharmazie. 330(3). 74–82. 14 indexed citations
15.
Dannhardt, Gerd, et al.. (1995). Regioisomeric 5(3)‐Aminomethyl‐3(5)‐phenylisoxazoles: Synthesis, Spectroscopic Discrimination, and Muscarinic Activity. Archiv der Pharmazie. 328(5). 437–443. 2 indexed citations
16.
Laufer, Stefan, J. Augustín, Gerd Dannhardt, & Werner Kiefer. (1994). (6,7-Diaryldihydropyrrolizin-5-yl)acetic Acids, a Novel Class of Potent Dual Inhibitors of Both Cyclooxygenase and 5-Lipoxygenase. Journal of Medicinal Chemistry. 37(12). 1894–1897. 100 indexed citations
17.
Dannhardt, Gerd, et al.. (1994). Synthesis and Muscarinic Activity of Isoxazole‐substituted 1,2,5,6‐Tetrahydropyridines. Archiv der Pharmazie. 327(11). 751–752.
18.
Dannhardt, Gerd, et al.. (1990). Antimykobakteriell wirksame 2‐Hydroxychinolizin‐4‐one. Archiv der Pharmazie. 323(6). 375–379. 4 indexed citations
19.
Dannhardt, Gerd, Peter Dominiak, & Stefan Laufer. (1990). Hypertensiv wirksame 5‐(β‐Aminoethyl)aminoisoxazole: Synthese und Prüfung von Derivaten mit teilrigidisierter C‐5‐Seitenkette bzw. ω‐ständigem Heterocyclus. Archiv der Pharmazie. 323(9). 571–578. 1 indexed citations
20.
Dannhardt, Gerd, et al.. (1979). Addition von Δ 1‐Pyrrolinyllithiumverbindungen an Carbonylderivate und Halogenalkane. Archiv der Pharmazie. 312(6). 498–507. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026